Hand hygiene
|
Aloe vera (L.) Burm.f. |
Aloin and aloe- emodin |
|
In vitro
|
Inhibiting the viral replication or destructing the virus lipid envelope |
26 |
Melaleuca alternifolia (Maiden & Betche) Cheel. |
Terpenes |
|
In vitro
|
Disrupting the viral membrane fusion procedure and viral replication |
25 |
Pre-exposure immunomodulation
|
Allium sativum L. (garlic) |
|
|
Animal (Rat) |
Boosting immune system cells and suppressing production of proinflammatory cytokines |
20, 22 |
Virus binding and entry
|
Ammoides verticillata (Desf.) Briq. |
Isothymol |
|
In silico |
ACE inhibitors |
30 |
Nigella sativa L. |
Dithymoquinone (DTQ) |
|
In silico |
ACE2 inhibitor |
33 |
Glycyrrhiza glabra L. |
Glycyrrhizin |
|
In silico |
ACE2 inhibitor |
85 |
Propolis |
Myricetin, Caffeic acid phenethyl ester, Hesperetin, Pinocembrin |
|
In silico |
Inhibitory potential with high binding energy to ACE2 (-8.97 kcal/mol) |
86 |
|
Kaempferol |
|
In silico |
Inhibitory potential with high binding energy to ACE2 (-7.5 kcal/mol) |
87 |
|
Quercetin |
|
In silico |
Inhibitory potential with high binding energy to ACE2 (-10.4 kcal/mol) |
88 |
Withania somnifera (L.) Dunal (Ashwagandha) |
Withaferin-A, Withanone, Caffeic acid phenethyl ester |
|
In silico, In vitro (MCF7 cells) |
TPMRSS2 inhibition |
28 |
Ziziphus rugosa Lam. |
Rugosanine B |
|
Computational screening |
Cathepsin L inhibition |
2 |
Senna occidentalis (L.) Link |
Ararobinol |
|
Computational screening |
Cathepsin L inhibition |
2 |
Hypecoum pendulum L. |
(+)- oxoturkiyenine |
|
Computational screening |
Cathepsin L inhibition |
2 |
Cinchona calisaya Wedd. |
3α,17α-cinchophylline |
|
Computational screening |
Cathepsin L inhibition |
2 |
Clerodendrum trichotomum Thunb. |
Trichotomine |
|
Computational screening |
Cathepsin L inhibition |
2 |
Tectona grandis L.f. |
Tectol |
|
Computational screening |
Cathepsin L inhibition |
2 |
Silybum marianum (L.) Gaertn. |
Silymonin |
|
Computational screening |
Cathepsin L inhibition |
2 |
Picrasma quassioides (D.Don) Benn. |
Picrasidine M |
|
Computational screening |
Cathepsin L inhibition |
2 |
Juglans regia L. |
Juglone |
|
Computational screening |
Cathepsin L inhibition |
2 |
Viral replication
|
Tinospora cordifolia (Willd.) Miers |
Berberine |
|
In silico |
Inhibition of 3CLpro function |
45 |
Anthemis hyalina DC.
|
|
|
In vitro (HeLa- CEACAM1a cells) |
Inhibition of TRP gene expression |
57 |
Asparagus
racemosus Willd. |
|
|
In silico |
Inhibition of N protein |
48 |
Glycyrrhiza glabra L. |
Glycyrrhizin |
|
In vitro
|
Inhibition of viral replication |
56 |
Immunomodulation and antiinflammation
|
Lophatherum gracile Brongn. |
|
|
In vivo
|
Enhancement of CD4+/CD8+ T cell ratio, inhibition of IL-Ιβ, TNF- α, and IFN-γ expression |
74 |
Panax ginseng C.A.Mey. |
Ginsenoside Rg1 |
|
|
Enhancement of CD4+ T cell activity |
72 |
Tanacetum parthenium (L.) |
Parthenolide |
|
In vitro, In vivo
|
Inhibition of IL-1, IL-2, IL-6, IL-8, and TNF-α expression |
79 |
Sch.Bip. (feverfew) |
|
|
|
|
|
Viscum album L. |
|
|
In vitro
|
Enhancement of CD4+ T cell migration |
75 |
Scutellaria
baicalensis Georgi |
|
|
In vivo
|
Inhibition of IL-1beta, IL- 2, IL-6, IL-12 and TNF-α expression |
76 |
Propolis |
Caffeic acid, and Caffeic acid phenethyl ester |
|
|
Downregulation and inhibition of PAK1 |
35 |
Biophytum
umbraculum
Welw.
|
|
|
In vitro (RAW 264.7 cell line) |
Anticomplement and antiinflammatory effects |
89 |
Anticomplement
|
Citrus
aurantium L. var. amara Engl. |
Eriocitrin/ neoeriocitrin, rhoifolin, hesperidin, naringin, rutin, veronicastroside, neohesperidin, and hesperetin |
|
In vitro
|
Anticomplement and antiinflammatory effects |
81 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|